Investor Prosight Management, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Prosight Management, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-06-26 13G MURA / Mural Oncology plc 900,000
2025-05-14 13G/A MGTX / MeiraGTx Holdings plc 4,052,714 4,356,571
2025-02-12 13G/A VINC / Vincerx Pharma, Inc. 1,678,635 111,755
2024-11-13 13G/A ADCT / ADC Therapeutics SA 6,471,800 9,617,531
2024-11-13 13G/A VINC / Vincerx Pharma, Inc. 2,497,218 1,678,635
2024-11-13 13G/A ADCT / ADC Therapeutics SA 6,471,800 9,627,017
2024-11-13 13G/A STTK / Shattuck Labs, Inc. 5,370,000 6,684,900
2024-08-16 13G/A STTK / Shattuck Labs, Inc. 2,782,797 5,370,000
2024-05-03 13G VINC / Vincerx Pharma, Inc. 2,497,218
2024-02-13 13G/A MGTX / MeiraGTx Holdings plc 4,080,804 4,052,714
2024-02-13 13G/A LBPH / Longboard Pharmaceuticals, Inc. 948,012 0
2024-02-13 13G/A KZR / Kezar Life Sciences, Inc. 4,073,229 3,365,333
2024-02-13 13G/A NSTGQ / NS Wind Down Co., Inc. 3,150,000 0
2024-02-13 13G/A ADCT / ADC Therapeutics SA 4,304,518 6,471,800
2024-02-13 13G/A ORIC / ORIC Pharmaceuticals, Inc. 2,280,778 1,578,263
2024-01-02 13G STTK / Shattuck Labs, Inc. 2,782,797 2,782,797
2023-09-01 13G NSTGQ / NS Wind Down Co., Inc. 3,150,000
2023-06-12 13G ORIC / ORIC Pharmaceuticals, Inc. 2,280,778
2023-05-15 13G MGTX / MeiraGTx Holdings plc 4,080,804 4,080,804
2023-04-21 13G KZR / Kezar Life Sciences, Inc. 4,073,229 4,073,229
2023-04-20 13G LBPH / Longboard Pharmaceuticals, Inc. 948,012
2023-04-17 13G ADCT / ADC Therapeutics SA 4,304,518 4,304,518
2022-02-14 13G/A XCUR / Exicure, Inc. 4,984,265 2,503,704
2021-08-20 13G XCUR / Exicure, Inc. 4,984,265
2021-02-12 13G/A ALDX / Aldeyra Therapeutics, Inc. 1,784,033 908,488
2020-02-25 13G ALDX / Aldeyra Therapeutics, Inc. 1,784,033
2020-02-14 13G/A TLGT / Teligent Inc 3,547,607 1,484,527
2019-02-14 13G/A TLGT / Teligent Inc 3,635,000 3,547,607
2019-02-14 13G/A TPST / Tempest Therapeutics, Inc. 256,739
2019-02-14 13G/A CDTX / Cidara Therapeutics, Inc. 1,647,879 245,764
2019-02-14 13G/A EIGR / Eiger BioPharmaceuticals, Inc. 678,793 0
2018-10-26 13G TPST / Tempest Therapeutics, Inc. 1,991,100
2018-05-07 13G TLGT / Teligent Inc 3,635,000
2018-02-13 13G/A EIGR / Eiger BioPharmaceuticals, Inc. 728,736 678,793
2018-02-13 13G/A CMRX / Chimerix, Inc. 2,462,456 1,478,519
2018-02-13 13G/A CDTX / Cidara Therapeutics, Inc. 873,630 1,647,879
2017-11-09 13G EIGR / Eiger BioPharmaceuticals, Inc. 728,736
2017-06-16 13G CDTX / Cidara Therapeutics, Inc. 873,630
2017-01-30 13G CMRX / Chimerix, Inc. 2,462,456
2016-02-12 13G/A BSTG / Biostage Inc 184,360
2015-02-19 13G BSTG / Biostage Inc 788,900